drugset
Drugs / MPL-001
last change Dec 2025 re-read 3 minutes ago

MPL-001

Traditional medicine (herbal / TCM)

Developed for
childhood malignant neoplasm · migraine disorder
Investigated by
University of Manitoba · Canadian Cancer Society (CCS) · Canadian Institutes of Health Research (CIHR) · SickKids Foundation

Trials 2

today NCT05754840 · Ph 1/2 NCT05337033 · Ph 2
202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT05754840 Jul 2025 → Dec 2026 expected childhood malignant neoplasm University of Manitoba Recruiting No outcome recorded
Phase 21 trial
Phase 2 NCT05337033 Oct 2024 → Dec 2025 overdue migraine disorder University of Manitoba Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as MPL-001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05754840 ↗
1

NCT05337033 ↗
Modality Traditional medicine (herbal / TCM) “cannabidiol-enriched cannabis herbal extract” NCT05754840 ↗